S. Van Den Hof et al., Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination, CLIN INF D, 32(1), 2001, pp. 2-8
We assessed antibodies to the capsular polysaccharide of Haemophilus influe
nzae type b (HibPS) in the Dutch population a few years after a mass vaccin
ation against H. influenzae (Hib) was begun. We observed sharp declines in
the geometric mean titer (GMT) and the prevalence of HibPS antibodies at le
vels of less than or equal to0.15 mug/mL in children who had received 4 dos
es of vaccine: from 8.65 mug/mL (prevalence, 99.4%) after 0-2 months to 0.8
mug/mL (prevalence, 83.3%) after 27-29 months. In adult groups, both the p
revalence of HibPS antibodies and the GMT declined significantly with incre
asing age but remained high (prevalence, greater than or equal to 83.7%; GM
T, 0.73 greater than or equal to mug/mL). We conclude that the overall immu
nity in the Dutch population seems satisfactory. We draw our conclusions fr
om the current serosurveillance study and from the sharp decline in invasiv
e Hib disease noted after the introduction of vaccination. The key question
s for the future are (1) whether Hib and cross-reacting organisms will circ
ulate sufficiently to provide natural reexposure, and (2) how long memory i
mmunity will persist after vaccination without reexposure.